Commercial stage specialty pharmaceutical company Fennec Pharmaceuticals (NASDAQ:FENC) (TSX:FRX:CA) said that Adrian Haigh has departed from his position as Fennec’s COO as of June 30, 2024. After nine years as an independent director, in August 2023, Adrian joined the Fennec leadership team as COO. “The company is actively searching for a U.S.-based leader,”Continue Reading
NiseriN/iStock via Getty Images Repsol (OTCQX:REPYY) (OTCQX:REPYF) is in talks to merge its U.K. North Sea oil and gas business with private equity-backed NEO Energy, with a deal potentially to be announced within weeks, Reuters reported Friday. A merger would create a company with production of more than 110K boe/day,Continue Reading
KeithBinns/E+ via Getty Images Astera Labs (NASDAQ:ALAB) plans to expand operations to India, the new site to be opened in Bangalore later this year will tap into the region’s engineering talent and establish a robust pipeline of interconnect technologies that enable AI architectures throughout the data center. “As a thrivingContinue Reading
Solitario Resources (NYSE:XPL) (TSX:SLR:CA) on Monday announced that its final revised plan of operations for its Golden Crest project has been signed by US Forest Service. The company added that the South Dakota board of minerals has accepted Solitario’s reclamation bond, paving the way for exploration drilling to begin. TheContinue Reading
